Venmax Drugs & Pharmaceuticals Limited has submitted a regulatory filing to BSE Limited intimating about an upcoming Board of Directors meeting. The meeting is scheduled for Monday, August 31, 2026 at 4:30 PM.
The agenda for the board meeting includes:
- Consideration and approval of the Notice of the 37th Annual General Meeting, Directors Report, and the 37th Annual Report of the Company along with annexures for the Financial Year 2025-26
- Decision on the date, time, and venue of the 37th Annual General Meeting of the Company
- Fixing the cut-off dates for determining the e-voting for the Annual General Meeting
- Consideration and approval of the appointment of Scrutinizer, e-voting agency, e-voting dates, and other necessary authorizations for the 37th Annual General Meeting
- Consideration and approval of the regularization of appointment of Additional Directors and change in designation of the Whole-time Director of the Company, subject to shareholder approval
- Any other business as the Board deems fit to discuss, with the permission of the Chairman
The intimation was made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document was digitally signed by Priyanka Agarwal, Company Secretary & Compliance Officer, on August 24, 2026 at 12:20:27 IST.
The company's registered office is located at Sy. No. 115, Brig Sayeed Road, Hanumanji Colony, Bowenpally, Picket, Hyderabad – 500009. Company CIN is L24230TG1988PLC009102 and GSTIN is 36AAACY1073C3ZM.